Publication

Concerns Over Participant Suicides Prematurely Abort a Clinical Trial of Potentially Significant Impact on Public Health: How Will We Make Progress in Timid Times?

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Joseph F Cubells, Emory University
Language
  • English
Date
  • 2011-04
Publisher
  • Current Medicine Group
Publication Version
Copyright Statement
  • © Springer Science+Business Media, LLC 2011
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1523-3812
Volume
  • 13
Issue
  • 2
Start Page
  • 80
End Page
  • 81
Abstract
  • Obesity, among the most common “preventable” causes of morbidity and premature mortality in developed societies, fundamentally arises from a mismatch between calories consumed (ie, feeding behavior, which in the rich world occurs in the setting of essentially unlimited availability of high-calorie foods) and calories expended (largely a function of how much or little a person uses weight-bearing musculature [ie, exercise behavior]). Thus, it is useful to view obesity and its adverse cardiovascular sequelae as behavioral disorders. The psychopharmacology of obesity is an important topic from the point of view of pharmacologic treatments aimed at influencing feeding behavior, as well as the myriad antipsychotic and antidepressant medications associated with changes in body weight.
Author Notes
  • Correspondence: Joseph F. Cubells, Departments of Human Genetics and Psychiatry and Behavioral Sciences, Emory University School of Medicine, 615 Michael Street, Suite 301, Atlanta, GA 30322, USA; Email: jcubell@emory.edu
Research Categories
  • Psychology, Behavioral

Tools

Relations

In Collection:

Items